Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NGNE
#3177
Neurogene, Inc. Common Stock
24.000
0
USD
+15.61%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+15.61%
Monthly Change
+11.11%
6 month change
-18.42%
Year Change
-18.42%
Previous Close
20.760
0
Open
24.000
0
Bid
Ask
Low
24.000
0
High
24.000
0
Volume
27
Markets
US Stock Market
Healthcare
NGNE
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
14.93 M
14.26 M
14.27 M
15.49 M
15.57 M
—
Valuation ratios
Enterprise value
204.7 M
96.24 M
154.55 M
197.43 M
216.99 M
665.21 M
Price to earnings ratio
-5.34
-2.69
-3.46
-4.21
-4.86
-15.21
Price to sales ratio
434.14
214.47
—
—
—
—
Price to cash flow ratio
-5.69
-3.05
-3.91
-4.52
-5.69
-17.17
Price to book ratio
1.29
0.24
0.28
0.3
1.66
2.49
Enterprise value to EBITDA ratio
-2.58
-1.11
-1.67
-2.1
-2.16
-7.04
Profitability ratios
Return on assets %
-0.06
-0.07
-0.07
-0.07
-0.09
-0.3
Return on equity %
-0.06
-0.08
-0.08
-0.08
-0.09
-0.33
Return on invested capital %
—
—
—
—
-525.41
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
20.84
21.03
18.07
18.39
16.56
74.05
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1
-0.99
-0.92
-0.92
-0.82
-3.65
EBIT per share
-1.22
-1.23
-1.24
-1.12
-1.29
-4.89
EBITDA per share
-1.18
-1.2
-1.2
-1.09
-1.26
-4.74
Total debt per share
—
—
—
—
—
—
Cash per share
17.78
13.94
13.04
12.54
12.61
52.13
Net current asset value per share
17.98
14.12
13.25
12.78
12.74
52.89
Tangible book value per share
17.67
13.9
12.98
12.54
12.42
51.84
Working capital per share
17.12
13.45
12.52
12.08
11.97
50.02
Book value per share
17.67
13.9
12.98
12.54
12.42
51.84
News
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026 - TipRanks.com
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts - TipRanks.com
Stifel sees rare disease stocks gaining after FDA official exit
Netflix, Dell among market cap stock movers on Friday
Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)
Neurogene stock surges 30% on FDA breakthrough therapy status
FDA grants breakthrough therapy status to Neurogene’s Rett drug
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin
Neurogene doses multiple patients in Rett syndrome gene therapy trial
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE)